Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Assessment of cognitive impairment in HSV-1 positive schizophrenia and bipolar patients: Systematic review and meta-analysis.

Tucker JD, Bertke AS.

Schizophr Res. 2019 Jul;209:40-47. doi: 10.1016/j.schres.2019.01.001. Epub 2019 Jan 11. Review.

PMID:
30639164
2.

HLA typing using genome wide data reveals susceptibility types for infections in a psychiatric disease enriched sample.

Parks S, Avramopoulos D, Mulle J, McGrath J, Wang R, Goes FS, Conneely K, Ruczinski I, Yolken R, Pulver AE, Pearce BD.

Brain Behav Immun. 2018 May;70:203-213. doi: 10.1016/j.bbi.2018.03.001. Epub 2018 Mar 21.

PMID:
29574260
3.

Letter to the Editor: NMDA receptor autoimmunity in mania following HSV encephalitis.

Blackman G, Moran N, Silber E, Symeon C, Brunnhuber F, Mazumder A, Jaffer F, Pollak T.

Psychol Med. 2018 May;48(7):1221-1223. doi: 10.1017/S0033291718000053. Epub 2018 Feb 14. No abstract available.

PMID:
29439749
4.

Differences in the association between persistent pathogens and mood disorders among young- to middle-aged women and men in the U.S.

Simanek AM, Parry A, Dowd JB.

Brain Behav Immun. 2018 Feb;68:56-65. doi: 10.1016/j.bbi.2017.09.017. Epub 2017 Sep 28.

PMID:
28965957
5.

Effects of Cumulative Herpesviridae and Toxoplasma gondii Infections on Cognitive Function in Healthy, Bipolar, and Schizophrenia Subjects.

Hamdani N, Daban-Huard C, Godin O, Laouamri H, Jamain S, Attiba D, Delavest M, Lépine JP, Le Corvoisier P, Houenou J, Richard JR, Yolken RH, Krishnamoorthy R, Tamouza R, Leboyer M, Dickerson FB.

J Clin Psychiatry. 2017 Jan;78(1):e18-e27. doi: 10.4088/JCP.15m10133.

PMID:
27929612
6.

Infection and inflammation in schizophrenia and bipolar disorder.

Tanaka T, Matsuda T, Hayes LN, Yang S, Rodriguez K, Severance EG, Yolken RH, Sawa A, Eaton WW.

Neurosci Res. 2017 Feb;115:59-63. doi: 10.1016/j.neures.2016.11.002. Epub 2016 Nov 14.

PMID:
27856235
7.

The association among smoking, HSV-1 exposure, and cognitive functioning in schizophrenia, bipolar disorder, and non-psychiatric controls.

Dickerson F, Adamos MB, Katsafanas E, Khushalani S, Origoni A, Savage CLG, Schroeder J, Schweinfurth LAB, Stallings C, Sweeney K, Yolken R.

Schizophr Res. 2016 Oct;176(2-3):566-571. doi: 10.1016/j.schres.2016.05.022. Epub 2016 Jun 1.

PMID:
27262384
8.

Toxoplasma gondii exposure may modulate the influence of TLR2 genetic variation on bipolar disorder: a gene-environment interaction study.

Oliveira J, Kazma R, Le Floch E, Bennabi M, Hamdani N, Bengoufa D, Dahoun M, Manier C, Bellivier F, Krishnamoorthy R, Deleuze JF, Yolken R, Leboyer M, Tamouza R.

Int J Bipolar Disord. 2016 Dec;4(1):11. doi: 10.1186/s40345-016-0052-6. Epub 2016 May 20.

9.

Exposure to Perinatal Infections and Bipolar Disorder: A Systematic Review.

Barichello T, Badawy M, Pitcher MR, Saigal P, Generoso JS, Goularte JA, Simões LR, Quevedo J, Carvalho AF.

Curr Mol Med. 2016;16(2):106-18. Review.

PMID:
26812921
10.

Cytomegalovirus Antibody Elevation in Bipolar Disorder: Relation to Elevated Mood States.

Prossin AR, Yolken RH, Kamali M, Heitzeg MM, Kaplow JB, Coryell WH, McInnis MG.

Neural Plast. 2015;2015:939780. doi: 10.1155/2015/939780. Epub 2015 May 13.

11.

An observational study of inflammation in the central nervous system in patients with bipolar disorder.

Stich O, Andres TA, Gross CM, Gerber SI, Rauer S, Langosch JM.

Bipolar Disord. 2015 May;17(3):291-302. doi: 10.1111/bdi.12244. Epub 2014 Aug 11.

PMID:
25109751
12.

Seroreactive marker for inflammatory bowel disease and associations with antibodies to dietary proteins in bipolar disorder.

Severance EG, Gressitt KL, Yang S, Stallings CR, Origoni AE, Vaughan C, Khushalani S, Alaedini A, Dickerson FB, Yolken RH.

Bipolar Disord. 2014 May;16(3):230-40. doi: 10.1111/bdi.12159. Epub 2013 Dec 6.

13.

Susceptibility genes are enriched in those of the herpes simplex virus 1/host interactome in psychiatric and neurological disorders.

Carter CJ.

Pathog Dis. 2013 Dec;69(3):240-61. doi: 10.1111/2049-632X.12077. Epub 2013 Sep 2.

PMID:
23913659
14.

Exposure to herpes simplex virus type 1 and cognitive impairments in individuals with schizophrenia.

Prasad KM, Watson AM, Dickerson FB, Yolken RH, Nimgaonkar VL.

Schizophr Bull. 2012 Nov;38(6):1137-48. doi: 10.1093/schbul/sbs046. Epub 2012 Apr 6. Review.

15.

Neonatal antibodies to infectious agents and risk of bipolar disorder: a population-based case-control study.

Mortensen PB, Pedersen CB, McGrath JJ, Hougaard DM, Nørgaard-Petersen B, Mors O, Børglum AD, Yolken RH.

Bipolar Disord. 2011 Nov-Dec;13(7-8):624-9. doi: 10.1111/j.1399-5618.2011.00962.x.

PMID:
22085475
16.

Serum antibodies to Toxoplasma gondii and Herpesvidae family viruses in individuals with schizophrenia and bipolar disorder: a case-control study.

Tedla Y, Shibre T, Ali O, Tadele G, Woldeamanuel Y, Asrat D, Aseffa A, Mihret W, Abebe M, Alem A, Medhin G, Habte A.

Ethiop Med J. 2011 Jul;49(3):211-20.

PMID:
21991754
17.

Impaired functioning in euthymic patients with bipolar disorder--HSV-1 as a predictor.

Gerber SI, Krienke UJ, Biedermann NC, Grunze H, Yolken RH, Dittmann S, Langosch JM.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jan 10;36(1):110-6. doi: 10.1016/j.pnpbp.2011.09.003. Epub 2011 Sep 14.

PMID:
21945379
18.

Association between cognitive functioning, exposure to Herpes Simplex Virus type 1, and the COMT Val158Met genetic polymorphism in adults without a psychiatric disorder.

Dickerson F, Stallings C, Sullens A, Origoni A, Leister F, Krivogorsky B, Yolken R.

Brain Behav Immun. 2008 Oct;22(7):1103-7. doi: 10.1016/j.bbi.2008.04.156. Epub 2008 Jun 20.

PMID:
18571372
19.

The lymphotoxin Cys13Arg polymorphism and cognitive functioning in individuals with schizophrenia.

Dickerson F, Boronow J, Stallings C, Origoni A, Yolken R.

Schizophr Res. 2007 Jan;89(1-3):173-6. Epub 2006 Oct 5.

PMID:
17029750
20.

Supplemental Content

Loading ...
Support Center